Followers | 28 |
Posts | 1125 |
Boards Moderated | 0 |
Alias Born | 11/05/2020 |
![](https://investorshub.advfn.com/uicon/763599.png?cb=1629814148)
Monday, March 21, 2022 9:19:37 PM
Good DD. Smart money is buying a biotech with unlimited upside. Be confident what you own! Best buy on the OTC at this point.
This is not smart money.
As Pumper already pointed out, before the AS increase Friday, there were 240 million shares not issued.
The fact that Koos had to increase the AS is a pretty clear message that 240 million doesn't cover what is about to come.
Even worse, here is a direct message from Koos himself as to where those shares are going:
On Friday Regen filed a Form 8K stating it had increased the authorized shares of its common stock. This action was undertaken because of contractual obligations to a noteholder.
What note holder do people think he is talking about? After all, the SEC filing about the AS increase came a day after the toxic loan payments started with Coventry Enterprises LLC. So, it's pretty clear.
Not only that, but the math conversion comes out to a few million shares a day over the next 5 months to cover that $1.5 million loan.
There won't be enough buys to sustain that for 5 straight months every single trading day. It's horrible.
Tell me, how do we spin this now?
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM